相关实验视频
Updated: Sep 10, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.5K
miR-150-5p通过向FTO来调节梅克尔细胞癌的进展,通过m6稳定CTNNB1
Bin Zheng1, Min Li1,2, Zixuan Gao1
1Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
Molecular carcinogenesis
|August 22, 2025
概括
通过向CTNNB1的关键调节剂FTO,MicroRNA-150-5p抑制了梅克尔细胞癌 (MCC) 的进展. 针对FTO可能为MCC提供新的治疗方法.
科学领域:
- 癌症学
- 分子生物学
- 表观遗传学
背景情况:
- 梅克尔细胞癌 (MCC) 是一种具有有限治疗选择的侵袭性皮肤癌.
- 微RNAs (miRNAs) 是细胞过程的关键调节者,但它们在MCC中的作用尚未完全理解.
- 在此之前,miR-150-5p已被确定在MCC转移中具有差异性表达.
研究的目的:
- 研究miR-150-5p在MCC进展中的功能作用.
- 确定在MCC中 miR-150-5p功能的分子标和机制.
主要方法:
- 基于细胞的测试来评估迁移和入侵.
- 使用生物信息工具和实验验证的直接miRNA目标的识别.
- 分析RNAN6-甲基氨酸 (m6A) 修饰及其对基因表达的影响.
- 西式抹杀和定量实时PCR测量基因和蛋白质水平.
主要成果:
- miR-150-5p抑制了MCC细胞的迁移和入侵.
- FTO (N6-甲基氨酸脱甲酶) 被确定为miR-150-5p的直接标.
- FTO促进了MCC细胞的增殖,迁移和入侵,其效应被miR-150-5p所挽救.
- FTO以m6A依赖的方式稳定了CTNNB1的转录,其中包括读者YTHDF2.
结论:
- 在MCC中,miR-150-5p通过抑制FTO作为瘤抑制剂.
- 通过稳定CTNNB1促进MCC的发展.
- miR-150-5p/FTO/CTNNB1轴代表了MCC的潜在治疗目标.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Master Transcription Regulators
7.0K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K

